Immunogenicity of SARS-CoV-2 vaccines in patients with cancer. (2022)
Attributed to:
Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.molmed.2022.07.006
PubMed Identifier: 35999131
Publication URI: http://europepmc.org/abstract/MED/35999131
Type: Journal Article/Review
Volume: 28
Parent Publication: Trends in molecular medicine
Issue: 12
ISSN: 1471-4914